Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-03-19
2000-06-06
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544317, A61K 31505, C07D23902
Patent
active
060719222
ABSTRACT:
A method and composition for the treatment of HIV infection, HBV infection, or abnormal cellular proliferation in humans and other host animals is disclosed that includes the administration of an effective amount of a 1,3-oxaselenolane nucleoside or a pharmaceutically acceptable salt thereof, optionally in a pharmaceutically acceptable carrier.
REFERENCES:
patent: 5041449 (1991-08-01), Belleau
patent: 5047407 (1993-09-01), Belleau
patent: 5149794 (1992-09-01), Yatvin
patent: 5194654 (1993-03-01), Hostetler
patent: 5204466 (1993-04-01), Liotta
patent: 5210085 (1993-05-01), Liotta et al.
patent: 5223263 (1993-06-01), Hostetler
patent: 5256641 (1993-10-01), Yatvin
patent: 5463092 (1995-10-01), Hostetler
patent: 5466806 (1995-11-01), Belleau et al.
patent: 5486520 (1996-01-01), Belleau et al.
patent: 5538975 (1996-07-01), Dionne
patent: 5539116 (1996-07-01), Liotta
patent: 5543389 (1996-08-01), Yatvin
patent: 5543390 (1996-08-01), Yatvin
patent: 5543391 (1996-08-01), Yatvin
patent: 5554728 (1996-09-01), Basava
patent: 5618820 (1997-04-01), Dionne
patent: 5700937 (1997-12-01), Liotta et al.
patent: 5728575 (1998-03-01), Liotta et al.
patent: 5814639 (1998-09-01), Liotta et al.
patent: 5827727 (1998-10-01), Liotta et al.
patent: 5892025 (1999-04-01), Liotta et al.
patent: 5914331 (1999-06-01), Liotta et al.
patent: 5914400 (1999-06-01), Liotta et al.
Du et. al., "Synthesis. Anti-Human Immunodeficiency Virus, and . . . ", J. Med. Chem., Sep. 12, 1997, vol. 40(19), pp. 2991-2993.
Chang, et al., Deoxycytidine Deaminase-resistant Stereoisomer is the Active Form of (-)-2',3'-thiacytidine in the Inhibition of Hepatitis B Virus Replication, Journal of Biological Chemistry, vol. 267(20), 13938-13942 (1992).
Davisson, et al., Synthesis of Nucleotide 5'-Diphosphates from 5'-O-Tosyl Nucleoside, J. Org. Chem., 52(9), 1794-1801 (1987).
Du J et al, Synthesis, "Anti-Human Immunodeficiency Virus and Anti-Hepatitis B Virus Activities of Novel Oxaselenolane Nucleosides," J of Med. Chem., (40)19, 2991-2993 (1997).
Furman, et al., "The Anti-Hepatitis B Virus Activities, Cytotoxicities, and Anabolic Profiles of the (-) and (+) Enantiomers of cis-5-Fluoro-1-[2-(Hydroxymethyl)-1,3-oxathioloane-5-yl]-Cytosine" Antimicrobial Agents and Chemotherapy,36(12) 2686-2692 (1992).
Ho, D.H.W., Distribution of Kinase and deaminase of 1 -D-rabinofuranosylcytosine in tissues of man and mouse. Cancer Res. 33, 2816-2820; (1973).
Hoard, et al., Conversion of Mono- and Oligodeoxyribonucleotides to 5'-Triphosphates, J. Am. Chem. Soc., 87(8), 1785-1788 (1965).
Hong, C.I., Nechaev, A., and West, C.R. (1979a) Synthesis and antitumor activity of 1 -3-arabinofuranosylcytosine conjugates of cortisol and cortisone. Biochem. Biophys. Rs. Commun. 88, 1223-1229(1979).
Hong, C.I., Nechaev, A., Kirisits, A.J. Buchheit, D.J. and West, C.R. (1980) Nucleoside conjugates. 6. Synthesis and comparison of antitumor activity of 1-(-D-arabinofuranosyl) cytosine conjugates of corticosteriods and selected lipophilic alcohols. J. Med. Chem. 28, 171-177.
Ji, Y.H., Monophosphoric Acid Diesters of 7 -Hydroxycholesterol and of Pyrimidine Nucleosides as Potential Antitumor Agents: Synthesis and preliminary Evaluation of Antitumor Activity, J. Med. Chem., 33,2264-2270, (1990).
Hostetler, K.Y., Korba, B. Sridhar, C., Gardener, M., Antiviral activity of phosphatidyl-dideoxycytidine in hepatitis B-infected cells and enhanced hepatic uptake in mice. Antiviral Res. 24, 59-67; (1994).
R. Jones and N. Bischofberger, Mini Review: Nucleotide prodrugs, Antiviral Research, 27, 1-17 (1995).
Kataoka, S., Uchida, R. and Yamaji, N. (1991) A convenient synthesis of adenosine 3',5' cyclic phosphate (cAMP) benzyl and methyl triesters. Heterocycles 32, 1351-1356.
Hostetler, K.Y., Richman, D.D., Sridhar, C.N. Felgner, P.L., Felgner, J., Ricci, J., Gerdener, M.F. Selleseth, D.W. and Ellis, M.N., Phosphatidylazidothymidine and phosphatidyl-ddC: Assessment of uptake in mouse lymphoid tissues and antiviral activities in human immunodeficiency virus-infected cells and in rauscher leukemia virus-infected mice. Antimicrobial Agents Chemother. 38 (12), 2792-2797; (1994).
Kinchington, D., Harvey, J.J., O'Connor, T.J., Jones, B.C.N.M., Devine, K.G., Taylor-Robinson, D., Jeffries, D.J. and McGuigan, C. (1992) Comparison of antiviral effects of zidovudine phosphoramidate and phosphorodiamidate derivatives against HIV and ULV in vitro. Antiviral Chem. Chemother. 3, 107-112.
Kodama, K., Morozumi, M., Saitoh, K.I., Kuninaka, H., Yoshino, H. and Saneyoshi, M., Antitumor activity and pharmacology of 1--D-arabinofuranosylcytosine-5'-stearylphosphate; an orally active derivative of 1--D-arabinofuranosylcytosine.
Korba and Milman, A cell culture assay for compounds which inhibit hepatitis B virus replication, Antiviral Res., 15:217 1991.
Kumar, A., Goe, P.L., Jones, A.S. Walker, R.T. Balzarini, J. and De Clercq, E. (1990) Synthesis and biological evaluation of some cyclic phosphoramidate nucleoside derivatives. J. Med. Chem. 33, 2368-2375.
LeBec, C., and Huynh-dinh, T., Synthesis of lipophilic phosphate triester derivatives of 5-fluorouridine and arabinocytidine as anticancer prodrugs, Tetrehedron Lett. 32, 6553-6556 (1991).
Lichtenstein, J., Barner, H.D. and Cohen S.S., The metabolism of exogenously supplied nucleotides by Escherichia coli., J. Biol. Chem. 235, 457-465; (1960).
McDougal, et al., Immunoassay for the Detection and Quanititation of Infectious Human Retrovirus. Lymphadenopathy-Associated Virus (LAV), J. Immun. Meth. 76, 171-183, (1985).
McGuigan, C. Tollerfield, S.M. and Riley, P.A., Synthesis and biological evaluation of some phosphate triester derivatives of the anti-viral drug Ara. Nucleic Acids Res. 17, 6065-6075; (1989).
McGuigan, C., Pathirana, R.N., Mahmood, N., Devine, K.G. and Hay, A.J., Aryl phosphate derivatives of AZT retain activity against HIV1 in cell lines which are resistant to the action of AZT. Antiviral Res. 17, 311-321 (1992).
McGuigan, C., O'Connor, T.J., Nicholls, S.R. Nickson, C. and Kinchington, D., Synthesis and anti-HIV activity of some novel substituted dialkyl phosphate derivatives of AZT and ddCyd., Antiviral Chem. Chemother. 1, 355-360; (1990).
McGuigan, C., Pathirana, R.N., Choi, S.M., Kinchington, D. and O'Connor, T.J., Phosphoramidate derivatives of AZT as inhibitors of HIV; studies on the caroxyl terminus. Antiviral Chem. Chemother. 4, 97-101; (1993).
McGuigan, C., Pathirana, R.N., Balzarini, J. and De Clercq, E. Intracellular delivery of bioactive AZT nucleotides by aryl phosphate derivatives of AZT. J. Med. Chem. 36, 1048-1052 (1993).
Meyer, R.B., Jr., Shuman, D.A. and Robins, R.K., Synthesis of purine nucleoside 3',5'-cyclic phosphoramidates. Tetrahedron Lett., 269-272; (1973).
Namane, A. Goyette, C., Fillion, M.P., Fillion, G. and Huynh-Dinh, T. (1992) Improved brain delivery of AZT using a glycosyl phosphotriester prodrug. J. Med. Chem. 35, 3939-3044.
Nargeot, J. Nerbonne, J.M. Engels, J. and Leser, H.A., Time course of the increase in the myocardial slow inward current after a photochemically generated concentration jump of intracelluar aAMP, Natl.
Norbeck, Tetrahedron Letters 30 (46), 6246 (1989).
Ohno, R., Tatsumi, N., Hirano, M., Imai, K. Mizoguchi, H., Nakamura, T., Kosaka, M., Takatuski, K., Yamaya, T., Toyama, K., Yoshida, T., Masaoka, T., Hashimoto, S., Ohshima, T., Kimura, I., Yamada, K. and Kimura, J., Treatment of myelodyspastic syndromes with orally administred 1--D-rabinofuranosylcytosine-5'-stearylphosphate. Oncology 48, 451-455 (1991).
Palomino, E., Kessle, D. and Horwitz, J.P., A dihydropyridine carrier system for sustained delivery of 2',3'dideoxynucleosides to the brain., J. Med. Chem. 32, 622-625; (1989).
Piantadosi, C., Marasco, C.J., Jr., Morris-Natschke, S.L., Meyer, K.L., Gumus, F., Surles, J.R., Ishaq, K.S., Kucera, L.S. Iyer, N., Wallen, C.A., Piantodosi, S. and Modest, E.J. (1991) Synthesis and evaluation of novel ether lipid nucleoside conjugates for anti-HIV-1 activity. J. Med. Chem. 34, 1408-1414.
Prisbe, E.J., Martin, J.C., McGee, D.P.C., Barker, M.F., Smee, D.F. Duke, A.E., Matthews, T.R. and Verheyden, J.P.
Chu Chung K.
Du Jinfa
Schinazi Raymond F.
Emory University
Haley Jacqueline
Knowles Sherry M.
Raymond Richard L.
The University of Georgia Research Foundation Inc.
LandOfFree
Synthesis, anti-human immunodeficiency virus, and anti-hepatitis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synthesis, anti-human immunodeficiency virus, and anti-hepatitis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthesis, anti-human immunodeficiency virus, and anti-hepatitis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2213829